California’s SB 41: A Gift to Big Pharma, Not Patients
⏱️ 6–7 min read
California families are struggling with skyrocketing prescription drug prices. Since 2017, prescription drug spending in our state-regulated health plans has increased by at least 56%—an increase of at least $5 billion. Depending on how you crunch the numbers, the real increase could be even higher. In 2022 alone, spending was $12.1 billion, up 12.3% from the year before. And it’s everyday Californians and their employers who are stuck footing the bill.
Instead of tackling the root problem, Sacramento has produced Senate Bill 41, written by Senator Scott Wiener and coauthored by fellow progressives in the Legislature. The bill is being pitched to voters as consumer protection, but in reality, it is a handout to the drug companies that dismantles cost-control tools and leaves patients paying the price.
Backed by Big Pharma, Not PatientsThe most telling endorsement isn’t coming from patients or small businesses. It’s coming from PhRMA, the D.C. lobbying arm of Big Pharma. If the very industry responsible for high drug prices is supporting your… Read More
